Specialization in Assisted Reproduction: Searching for Sterility Origin

Saturday, October 1, 2022, 10:18 AM - Tuesday, September 30, 2025, 12:00 AM


AMA PRA Category 1 Credits™ (30.00 hours), Non-Physician Attendance (30.00 hours)

The number of women and couples accessing assisted reproductive technology (ART) is increasing every year, primarily because parenthood has been postponed.

The evaluation and management of infertility has changed substantially over the past ten to fifteen years. Several tests, proven to be of limited value in the study of patients, have been discarded and replaced by newer and more effective tests, while significant advances have been made in ultrasound evaluation. In addition, there have been advances in the surgical approach to pathologies related to sterility, which have led to a greater use of endoscopy and less invasive techniques.

Clinicians who treat patients with infertility face several challenges in selecting the appropriate diagnostic and treatment options for both their male and female patients. Some of the options, particularly when related to advanced maternal age or low responders, are not well-known among gynecologists and primary care physicians. Also, among gynecologists and PCPs there is still not a clear understanding regarding the precise indications of treatment in male/female infertility and some pathologies, such as in the case of adenomyosis.

This education program has been developed to help clinicians better diagnose and treat sterility.

1. Discuss adenomyosis effect on reproductive outcomes.
2. Apply a systematic examination method for infertility assessment.
3. Assess reproductive pathologies using ultrasound.
4. Make use of ultrasound in the follow-up of Assisted Reproduction Techniques.
5. Explain the effect of endometriosis on reproductive outcomes.
6. Discuss about the better treatment options for reproductive management of uterine fibroids.
7. Discuss about the best surgical approach to Müllerian malformations in Reproductive Medicine.
8. Analyze the role of hydrosalpinx in infertility.
9. Choose the best technique for hydrosalpinx diagnosis.
10. List the consequences of a low ovarian response in reproduction.
11. Interpret semen analysis results and how external factor can affect to its results.
12. Identify what varicocele is and its relationship with infertility.
13. Assess therapeutic options for varicocele.
14. Choose the best treatment option for the main seminal tract infections.
15. Explain how sperm freezing is performed and how sperm freeze samples are managed.
16. List the main genetic causes (karyotype alterations, monogenic causes and other genetic syndromes) related to infertility.

To register for this activity, click here. By clicking on the link, you will be taken to the IVIRMA Global Education website.

Have questions or need learner support? Send an email to [email protected].

 

In support of improving patient care, this activity has been planned and implemented by Thomas Jefferson University and IVIRMA Global Education. Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 30.00 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals: This educational activity is designated for 30.00 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity. 

Jefferson Release Policy

Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy

As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Planning Committee

No member of the planning committee have any relevant financial relationships to disclose.
William Schlaff, MD
Juan Giles, MD, PhD

Faculty

No member of faculty have any relevant financial relationships to disclose.
José Manuel Puente, MD, PhD
Cinzia Caligara, MD
Eliseo Sánchez, MD
Jose Mª Pomerol, MD
Javier Martínez Salazar, MD
Carlos Balmori, MD
Rocío Rivera, PhD
Sandra González, MD, PhD
Judith Reina,  PhD

The following faculty have relevant financial relationships to disclose.
Jose Mª Martínez Jabaloyas, MD
  Advisor/Speaker: Astellas; Researcher/Speaker: Janssen
Alberto Vázquez, MD
  Advisor: Olympus
Prof. Juan Antonio García Velasco, MD, PhD
  Speaker: Merck, MSD, Organon, Ferring, Gedeon, Richter

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

 

This educational activity received no commercial or in-kind support.